Skip to main content
. Author manuscript; available in PMC: 2008 May 5.
Published in final edited form as: Clin Neurophysiol. 2004 Jul;115(7):1583–1591. doi: 10.1016/j.clinph.2004.02.015

Table 4.

Mean (SD) P3a and P3b amplitude (μV) and latency (ms) for control and HIV

P3a amplitude
P3a latency
P3b amplitude
P3b latency
Control HIV P Control HIV P Control HIV P Control HIV P
Fz 13.76 (4.94) 6.31 (4.76) <0.01 311.2 (36.1) 320.5 (22.9) NS 9.49 (4.21) 3.21 (3.99) <0.01 330.1 (28.4) 355.2 (49.7) NS
FCz 16.03 (6.14) 6.86 (5.38) <0.01 308.5 (35.7) 325.1 (20.3) NS 10.18 (4.95) 3.41 (4.70) <0.01 332.8 (32.1) 357.9 (50.8) NS
Cz 16.11 (6.82) 7.48 (4.60) <0.01 313.1 (35.3) 328.8 (19.7) NS 9.96 (5.54) 4.22 (5.14) <0.05 343.7 (35.2) 401.1 (70.3) < 0.05
CPz 15.65 (6.95) 7.89 (4.48) <0.01 318.0 (37.1) 328.8 (19.7) <0.05 12.24 (3.95) 7.72 (5.90) <0.05 368.8 (58.6) 406.7 (60.4) NS
Pz 15.23 (6.96) 8.01 (4.05) <0.05 310.7 (33.1) 330.7 (19.6) <0.05 13.71 (3.24) 9.59 (6.22) NS 361.6 (39.0) 397.6 (58.6) < 0.05
POz 13.38 (6.76) 7.23 (4.00) <0.05 304.0 (34.1) 329.1 (17.8) <0.05 12.69 (2.67) 9.85 (6.03) NS 369.6 (50.5) 389.1 (55.3) NS

With BDI as covariate.